Figure 8 Investment Strategies LLC bought a new stake in Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 12,288 shares of the company’s stock, valued at approximately $747,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Blume Capital Management Inc. purchased a new position in shares of Vivmark Residential Common Shares of Beneficial Interest during the 3rd quarter worth about $25,000. Physician Wealth Advisors Inc. purchased a new stake in Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter worth about $27,000. Farmers & Merchants Investments Inc. purchased a new stake in Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter worth about $31,000. Planning Strategies Inc. raised its position in Vivmark Residential Common Shares of Beneficial Interest by 87.5% in the 3rd quarter. Planning Strategies Inc. now owns 538 shares of the company’s stock worth $33,000 after purchasing an additional 251 shares during the period. Finally, Mather Group LLC. bought a new stake in Vivmark Residential Common Shares of Beneficial Interest in the third quarter worth about $33,000. Hedge funds and other institutional investors own 92.68% of the company’s stock.
Vivmark Residential Common Shares of Beneficial Interest Trading Up 0.9%
NYSE VMRK opened at $64.78 on Tuesday. The business has a 50-day moving average of $62.56. The company has a current ratio of 0.58, a quick ratio of 0.19 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $24.29 billion, a PE ratio of 239.91, a PEG ratio of 3.76 and a beta of 0.72. Vivmark Residential Common Shares of Beneficial Interest has a 12 month low of $57.57 and a 12 month high of $71.50.
Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK – Get Free Report) last posted its quarterly earnings results on Wednesday, July 22nd. The company reported $0.30 EPS for the quarter. Vivmark Residential Common Shares of Beneficial Interest had a negative net margin of 4.21% and a negative return on equity of 0.80%. The company had revenue of $785.05 million for the quarter. As a group, sell-side analysts forecast that Vivmark Residential Common Shares of Beneficial Interest will post 4.08 earnings per share for the current year.
Vivmark Residential Common Shares of Beneficial Interest Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, October 16th. Shareholders of record on Monday, October 5th were paid a $0.7025 dividend. This represents a $2.81 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date was Monday, October 5th. Vivmark Residential Common Shares of Beneficial Interest’s dividend payout ratio is currently 1,040.74%.
Insider Buying and Selling
In other Vivmark Residential Common Shares of Beneficial Interest news, Director Chris Carr sold 1,130 shares of the company’s stock in a transaction dated Wednesday, September 9th. The shares were sold at an average price of $65.28, for a total value of $73,766.40. Following the transaction, the director directly owned 4,461 shares in the company, valued at $291,214.08. This represents a 20.21% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In the last 90 days, insiders have sold 1,680 shares of company stock valued at $109,739. 1.20% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on the company. Wells Fargo & Company dropped their target price on Vivmark Residential Common Shares of Beneficial Interest from $72.00 to $68.00 and set an “overweight” rating for the company in a research report on Monday, October 19th. Stifel Nicolaus set a $77.50 target price on Vivmark Residential Common Shares of Beneficial Interest in a research note on Monday, November 9th. Piper Sandler reduced their price target on Vivmark Residential Common Shares of Beneficial Interest from $76.00 to $67.00 and set a “neutral” rating on the stock in a report on Monday, October 12th. Morgan Stanley assumed coverage on Vivmark Residential Common Shares of Beneficial Interest in a research note on Tuesday, August 25th. They set an “overweight” rating and a $75.00 price target for the company. Finally, BMO Capital Markets decreased their price target on Vivmark Residential Common Shares of Beneficial Interest from $75.00 to $74.00 and set a “market perform” rating for the company in a research note on Monday, August 24th. Five equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Vivmark Residential Common Shares of Beneficial Interest currently has a consensus rating of “Hold” and an average target price of $71.50.
Get Our Latest Stock Analysis on VMRK
Vivmark Residential Common Shares of Beneficial Interest Profile
Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.
Featured Articles
- Five stocks we like better than Vivmark Residential Common Shares of Beneficial Interest
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Want to see what other hedge funds are holding VMRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK – Free Report).
Receive News & Ratings for Vivmark Residential Common Shares of Beneficial Interest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivmark Residential Common Shares of Beneficial Interest and related companies with MarketBeat.com's FREE daily email newsletter.
